Meral Gunaldi1, Sema Goksu2, Dilek Erdem3, Seyda Gunduz4, Yildiz Okuturlar5, Eda Tiken6, Sibel Kahraman7, Yesim Ozdem Inan5, Tugrul Burak Genc5, Mustafa Yildirim8. 1. Department of Medical Oncology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital Istanbul, Turkey. 2. Department of Medical Oncology, Kayseri Research and Training Hospital Kayseri, Turkey. 3. Department of Medical Oncology, Samsun Medical Park Hospital Samsun, Turkey. 4. Department of Medical Oncology, Antalya Research and Training Hospital Antalya, Turkey. 5. Department of Internal Medicine, Bakirkoy Dr. Sadi Konuk Training and Research Hospital Istanbul, Turkey. 6. Department of Radiation Oncology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital Istanbul, Turkey. 7. Department of Pathology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital Istanbul, Turkey. 8. Department of Medical Oncology, Gaziantep Medical Park Hospital Gaziantep, Turkey.
Abstract
BACKGROUND: Increasing amounts of evidence suggest patient-related systemic inflammatory response (SIR) as a powerful prognostic factor in cancer and applicability of SIR as a prognostic factor has been investigated. AIM: To evaluate the prognostic significance of SIR, which is among routinely analysed blood parameters in patients with all stages of gastric cancer (GC). METHODS: A total of 245 patients with gastric cancer who were followed up and treated in four clinics of medical oncology were included in the study. At first admission of the patients, from routinely determined whole blood cell counts in medical oncology clinics, their neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) values were estimated and recorded before initiating chemo- or radiotherapy. A univariate non-parametric analytical method and chi-square test examined the correlation between prognostic factors, and survival rates. Survival curves were estimated using the Kaplan-Meier method. RESULTS: Sixty-eight (27.8%) female and 177 (72.2) male patients (total n=245) were included in the study. When NLR was used as an indicator of SIR, 108 (44.1%) patients were SIR negative and 137 (55.9%) patients were SIR positive. When PLR was used as an indicator of SIR, SIR negativity and positivity were detected in 93(38%) and 152 (62%) patients, respectively. A statistically significant correlation was found between status of lymph node metastasis, stage of the disease and NLR (P=0.001, P=0.017). SIR determined with PLR was found to be correlated with the depth of tumor invasion and stage of the disease (P=0.016, P=0.033). A significant correlation was not detected between PLR and survival (P=0.405). CONCLUSION: According to our study, parameters of NLR and PLR calculated preoperatively from peripheral blood samples can be used in patients with various sizes of tumours in different disease stages. Still based on our results, NLR calculated during diagnostic workup is a parameter with a prognostic value. In addition, NLR is a determinative factor in the selection of surgical method and chemotherapeutic modalities, which also functions as a potential contributory marker in effective immunotherapeutic strategies.
BACKGROUND: Increasing amounts of evidence suggest patient-related systemic inflammatory response (SIR) as a powerful prognostic factor in cancer and applicability of SIR as a prognostic factor has been investigated. AIM: To evaluate the prognostic significance of SIR, which is among routinely analysed blood parameters in patients with all stages of gastric cancer (GC). METHODS: A total of 245 patients with gastric cancer who were followed up and treated in four clinics of medical oncology were included in the study. At first admission of the patients, from routinely determined whole blood cell counts in medical oncology clinics, their neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) values were estimated and recorded before initiating chemo- or radiotherapy. A univariate non-parametric analytical method and chi-square test examined the correlation between prognostic factors, and survival rates. Survival curves were estimated using the Kaplan-Meier method. RESULTS: Sixty-eight (27.8%) female and 177 (72.2) male patients (total n=245) were included in the study. When NLR was used as an indicator of SIR, 108 (44.1%) patients were SIR negative and 137 (55.9%) patients were SIR positive. When PLR was used as an indicator of SIR, SIR negativity and positivity were detected in 93(38%) and 152 (62%) patients, respectively. A statistically significant correlation was found between status of lymph node metastasis, stage of the disease and NLR (P=0.001, P=0.017). SIR determined with PLR was found to be correlated with the depth of tumor invasion and stage of the disease (P=0.016, P=0.033). A significant correlation was not detected between PLR and survival (P=0.405). CONCLUSION: According to our study, parameters of NLR and PLR calculated preoperatively from peripheral blood samples can be used in patients with various sizes of tumours in different disease stages. Still based on our results, NLR calculated during diagnostic workup is a parameter with a prognostic value. In addition, NLR is a determinative factor in the selection of surgical method and chemotherapeutic modalities, which also functions as a potential contributory marker in effective immunotherapeutic strategies.
Authors: Mi Sook Gwak; Soo Joo Choi; Jie Ae Kim; Justin Sang Ko; Tae Hyeong Kim; Sang Min Lee; Jung A Park; Myung Hee Kim Journal: J Korean Med Sci Date: 2007-09 Impact factor: 2.153
Authors: H Schmidt; L Bastholt; P Geertsen; I J Christensen; S Larsen; J Gehl; H von der Maase Journal: Br J Cancer Date: 2005-08-08 Impact factor: 7.640